Announce Date | 11/21/2024 |
EPS Normalized Actual | $0.04 (Miss by $-0.05) |
EPS GAAP Actual | $0.04 (Miss by $-0.05) |
Revenue Actual | $0.025286B |
Revenue Surprise | Beat by $25.286M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.11 |
EPS GAAP Estimate | $0.11 |
Revenue Estimate | $0.0275B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2026 | 0.35 | 31.29 | 0.32209 | 0.40798 | 0 |
Apr 2025 | 0.37 | 29.59 | 0.37 | 0.45 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Oct 2024) | -0.06 | -0.17 | 0.025286B | -1.6% | -0.38M |
FQ1 2025 (Jan 2025) | -0.08 | -0.176133 | 0.025007B | -2.12% | -1.39M |
FQ3 2024 (Jul 2024) | 0.0617 | -0.04497 | 0.026192B | -11.36% | 1.26M |
FQ2 2024 (Apr 2024) | 0.0654 | -1.51105 | 0.025388B | -17.83% | -12.49M |
FQ1 2024 (Jan 2024) | 0.12 | 0.03 | 0.025536B | -21.44% | -3.15M |
FQ4 2023 (Oct 2023) | 0.07 | 0.07 | 0.02569B | -22.37% | 25.69M |
FQ3 2023 (Jul 2023) | 0.08 | 0.08 | 0.029168B | -7.3% | 29.17M |
FQ2 2023 (Apr 2023) | 0.08 | 0.08 | 0.029914B | -15.83% | 29.91M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
0.11
Consensus Revenue Estimates
0.0275B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2026 (May 2026) | 0.115 | -- | 0.11389 | 0.11595 | 0 |
FQ1 2026 (Jan 2026) | 0.105 | 176.19 | 0.10428 | 0.10561 | 0 |
FQ4 2025 (Oct 2025) | 0.11 | 154.55 | 0.10419 | 0.11399 | 1 |
FQ3 2025 (Jul 2025) | 0.11 | 43.91 | 0.10419 | 0.11399 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2026 (May 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ1 2026 (Jan 2026) | 0.03B | 10.37 | 0.03B | 0.03B | 1 |
FQ4 2025 (Oct 2025) | 0.03B | 9.69 | 0.03B | 0.03B | 0 |
FQ3 2025 (Jul 2025) | 0.03B | 4.76 | 0.03B | 0.03B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | 0.11 | -0.06 | -0.17 | 283.33% |
FQ1 2025 (Jan 2025) | 0.096133 | -0.08 | -0.176133 | 220.17% |
FQ3 2024 (Jul 2024) | 0.10667 | 0.0617 | -0.04497 | -72.88% |
FQ2 2024 (Apr 2024) | 1.57645 | 0.0654 | -1.51105 | -2310.47% |
FQ1 2024 (Jan 2024) | 0.09 | 0.12 | 0.03 | 25% |
FQ4 2023 (Oct 2023) | 0.07 | 0.07 | 100% | |
FQ3 2023 (Jul 2023) | 0.08 | 0.08 | 100% | |
FQ2 2023 (Apr 2023) | 0.08 | 0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | $0.03B | $0.03B | $-0.38M | -1.51% |
FQ1 2025 (Jan 2025) | $0.03B | $0.03B | $-1.39M | -5.57% |
FQ3 2024 (Jul 2024) | $0.02B | $0.03B | $1.26M | 4.81% |
FQ2 2024 (Apr 2024) | $0.04B | $0.03B | $-12.49M | -49.18% |
FQ1 2024 (Jan 2024) | $0.03B | $0.03B | $-3.15M | -12.35% |
FQ4 2023 (Oct 2023) | $0B | $0.03B | $25.69M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.03B | $29.17M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.03B | $29.91M | 100% |